{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:04:29Z","timestamp":1792803869879,"version":"4.5.0"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Detection of 1,3-\u03b2-d-glucan (BDG) in serum has been evaluated for its inclusion as a mycological criterion of invasive fungal infections (IFI) according to EORTC and Mycoses Study Group (MSG) definitions. BDG testing may be useful for the diagnosis of both invasive aspergillosis and invasive candidiasis, when interpreted in conjunction with other clinical\/radiological signs and microbiological markers of IFI. However, its performance and utility vary according to patient population (hematologic cancer patients, solid-organ transplant recipients, intensive care unit patients) and pretest likelihood of IFI. The objectives of this article are to provide a systematic review of the performance of BDG testing and to assess recommendations for its use and interpretation in different clinical settings.<\/jats:p>","DOI":"10.1093\/cid\/ciaa1943","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T03:51:09Z","timestamp":1612497069000},"page":"S102-S108","source":"Crossref","is-referenced-by-count":81,"title":["Assessment of the Role of 1,3-\u03b2-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults"],"prefix":"10.1093","volume":"72","author":[{"given":"F","family":"Lamoth","sequence":"first","affiliation":[{"name":"Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"},{"name":"Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Akan","sequence":"additional","affiliation":[{"name":"Ankara University, Faculty of Medicine, Cebeci Campus, Hematology Clinical Research Unit, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Andes","sequence":"additional","affiliation":[{"name":"Department of Medicine and Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Cruciani","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, G. Fracastoro Hospital, San Bonifacio, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Marchetti","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"},{"name":"Department of Medicine, Ensemble Hospitalier de La C\u00f4te, Morges, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Ostrosky-Zeichner","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, McGovern Medical School, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Racil","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Blood Transfusion, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Clancy","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"2021031205091013500_CIT0001","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cll.2014.02.006","article-title":"Nonmolecular methods for the diagnosis of respiratory fungal infections","volume":"34","author":"Lamoth","year":"2014","journal-title":"Clin Lab Med"},{"key":"2021031205091013500_CIT0002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1469-0691.2011.03760.x","article-title":"Accuracy of \u03b2-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis","volume":"19","author":"Karageorgopoulos","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"2021031205091013500_CIT0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JCM.05267-11","article-title":"Diagnostic accuracy of serum 1,3-\u03b2-D-glucan for Pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis","volume":"50","author":"Onishi","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2021031205091013500_CIT0004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0009-8981(85)90273-6","article-title":"A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications","volume":"149","author":"Obayashi","year":"1985","journal-title":"Clin Chim Acta"},{"key":"2021031205091013500_CIT0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jmii.2014.06.009","article-title":"A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-\u03b2-D-glucan for invasive fungal infection: focus on cutoff levels","volume":"48","author":"He","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"2021031205091013500_CIT0006","doi-asserted-by":"crossref","first-page":"e0131602","DOI":"10.1371\/journal.pone.0131602","article-title":"The Screening Performance of serum 1,3-beta-D-glucan in patients with invasive fungal diseases: a meta-analysis of prospective cohort studies","volume":"10","author":"Hou","year":"2015","journal-title":"PLoS One"},{"key":"2021031205091013500_CIT0007","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"\u03b2-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021031205091013500_CIT0008","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","article-title":"\u03b2-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021031205091013500_CIT0009","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.2169\/internalmedicine.50.6175","article-title":"Diagnosis of invasive fungal disease using serum (1\u21923)-\u03b2-D-glucan: a bivariate meta-analysis","volume":"50","author":"Lu","year":"2011","journal-title":"Intern Med"},{"key":"2021031205091013500_CIT0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/ajcp\/aqy135","article-title":"Diagnostic accuracy of \u03b2-d-glucan (Fungitell) testing among patients with hematologic malignancies or solid organ tumors: a systematic review and meta-analysis","volume":"151","author":"White","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"2021031205091013500_CIT0011","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1515\/med-2018-0050","article-title":"Diagnostic efficacy of serum 1,3-\u03b2-D-glucan for invasive fungal infection: an update meta-analysis based on 37 case or cohort studies","volume":"13","author":"Xiaoling","year":"2018","journal-title":"Open Med (Wars)"},{"key":"2021031205091013500_CIT0012","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2021031205091013500_CIT0013","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.rmed.2016.05.017","article-title":"Diagnostic value of (1 \u2192 3)-\u03b2-D-glucan in bronchoalveolar lavage fluid for invasive fungal disease: A meta-analysis","volume":"117","author":"Shi","year":"2016","journal-title":"Respir Med"},{"key":"2021031205091013500_CIT0014","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/cid\/cit808","article-title":"Utility of (1-3)-\u03b2-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections","volume":"58","author":"Litvintseva","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021031205091013500_CIT0015","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/JCM.00061-13","article-title":"Cerebrospinal fluid (1,3)-\u03b2-D-glucan detection as an aid for diagnosis of iatrogenic fungal meningitis","volume":"51","author":"Lyons","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2021031205091013500_CIT0016","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021031205091013500_CIT0017","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2011.178","article-title":"ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients","volume":"47","author":"Marchetti","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"2021031205091013500_CIT0018","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1099\/jmm.0.019299-0","article-title":"Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies\u2014high frequency of false-positive results and their analysis","volume":"59","author":"Racil","year":"2010","journal-title":"J Med Microbiol"},{"key":"2021031205091013500_CIT0019","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cmi.2020.02.036","article-title":"Impact of intravenous and subcutaneous immunoglobulins on false positivity of galactomannan and \u03b2-D-glucan antigenaemia and detection of circulating Aspergillus fumigatus DNA","volume":"26","author":"Bougnoux","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2021031205091013500_CIT0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/CVI.00009-09","article-title":"Detection of (1\u2013&gt;3)-beta-D-glucan as an adjunct to diagnosis in a mixed population with uncommon proven invasive fungal diseases or with an unusual clinical presentation","volume":"16","author":"Cu\u00e9tara","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"2021031205091013500_CIT0021","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/647942","article-title":"Diagnostic performance of the (1\u2013&gt;3)-beta-D-glucan assay for invasive fungal disease","volume":"49","author":"Koo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021031205091013500_CIT0022","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/myc.12918","article-title":"Performance of 1,3-beta-D-glucan in the diagnosis and monitoring of invasive fusariosis","volume":"62","author":"Nucci","year":"2019","journal-title":"Mycoses"},{"key":"2021031205091013500_CIT0023","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/421944","article-title":"Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome","volume":"39","author":"Odabasi","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2021031205091013500_CIT0024","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u2013&gt;3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2021031205091013500_CIT0025","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ijid.2011.09.017","article-title":"Is elevation of the serum \u03b2-d-glucan level a paradoxical sign for Trichosporon fungemia in patients with hematologic disorders?","volume":"16","author":"Nakase","year":"2012","journal-title":"Int J Infect Dis"},{"key":"2021031205091013500_CIT0026","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0609.2010.01410.x","article-title":"Fatal Trichosporon fungemia in patients with hematologic malignancies","volume":"84","author":"Suzuki","year":"2010","journal-title":"Eur J Haematol"},{"key":"2021031205091013500_CIT0027","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/JCM.00506-08","article-title":"Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients","volume":"47","author":"Hachem","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2021031205091013500_CIT0028","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JCM.42.6.2733-2741.2004","article-title":"Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1\u2013&gt;3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders","volume":"42","author":"Kawazu","year":"2004","journal-title":"J Clin Microbiol"},{"key":"2021031205091013500_CIT0029","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/JCM.43.1.299-305.2005","article-title":"Contribution of (1-&gt;3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan","volume":"43","author":"Pazos","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2021031205091013500_CIT0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/jof6040253","article-title":"Comparison of beta-D-glucan and galactomannan in serum for detection of invasive aspergillosis: retrospective analysis with focus on early diagnosis","volume":"6","author":"Dichtl","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2021031205091013500_CIT0031","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.diagmicrobio.2018.08.005","article-title":"The performance of galactomannan in combination with 1,3-\u03b2-D-glucan or Aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: evidences from 13 studies","volume":"93","author":"Zhang","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021031205091013500_CIT0032","first-page":"745","article-title":"Computed tomographic scan of the chest, latex agglutination test and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients","volume":"85","author":"Kami","year":"2000","journal-title":"Haematologica"},{"key":"2021031205091013500_CIT0033","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/527382","article-title":"1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia","volume":"46","author":"Senn","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2021031205091013500_CIT0034","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2018.01.011","article-title":"Usefulness of \u00df-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients","volume":"76","author":"Guitard","year":"2018","journal-title":"J Infect"},{"key":"2021031205091013500_CIT0035","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1111\/j.1469-0691.2012.03777.x","article-title":"Post-diagnostic kinetics of the (1 \u2192 3)-\u03b2-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia","volume":"18","author":"Koo","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2021031205091013500_CIT0036","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s15010-007-6240-7","article-title":"Preemptive treatment of fungal infection based on plasma (1 \u2013&gt; 3)beta-D-glucan levels after liver transplantation","volume":"35","author":"Akamatsu","year":"2007","journal-title":"Infection"},{"key":"2021031205091013500_CIT0037","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1128\/JCM.01183-10","article-title":"The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation","volume":"48","author":"Alexander","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2021031205091013500_CIT0038","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/JCM.03018-14","article-title":"Contribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation","volume":"53","author":"Levesque","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2021031205091013500_CIT0039","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/ijms18040862","article-title":"Detection of (1,3)-beta-d-glucan for the diagnosis of invasive fungal infection in liver transplant recipients","volume":"18","author":"Levesque","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2021031205091013500_CIT0040","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/TP.0000000000000635","article-title":"Bronchoalveolar lavage fluid (1,3)\u03b2-D-glucan for the diagnosis of invasive fungal infections in solid organ transplantation: a prospective multicenter study","volume":"99","author":"Mutschlechner","year":"2015","journal-title":"Transplantation"},{"key":"2021031205091013500_CIT0041","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1097\/TP.0000000000000763","article-title":"Performance characteristics of galactomannan and \u03b2-d-glucan in high-risk liver transplant recipients","volume":"99","author":"Singh","year":"2015","journal-title":"Transplantation"},{"key":"2021031205091013500_CIT0042","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1469-0691.2010.03357.x","article-title":"A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1\u2192 3)-\u03b2-d-glucan chromogenic assay in serum samples","volume":"17","author":"Acosta","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2021031205091013500_CIT0043","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10096-011-1365-0","article-title":"Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-\u03b2-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease","volume":"31","author":"Acosta","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021031205091013500_CIT0044","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcrc.2018.07.001","article-title":"Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study","volume":"47","author":"Boch","year":"2018","journal-title":"J Crit Care"},{"key":"2021031205091013500_CIT0045","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2169\/internalmedicine.53.2381","article-title":"Diagnostic value of the serum galactomannan and (1, 3)-\u03b2-D-glucan assays for invasive pulmonary aspergillosis in non-neutropenic patients","volume":"53","author":"Cai","year":"2014","journal-title":"Intern Med"},{"key":"2021031205091013500_CIT0046","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/JCM.00879-11","article-title":"Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study","volume":"49","author":"De Vlieger","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2021031205091013500_CIT0047","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13054-017-1763-5","article-title":"Combined use of serum (1,3)-\u03b2-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units","volume":"21","author":"Giacobbe","year":"2017","journal-title":"Crit Care"},{"key":"2021031205091013500_CIT0048","doi-asserted-by":"crossref","first-page":"e42282","DOI":"10.1371\/journal.pone.0042282","article-title":"\u03b2-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study","volume":"7","author":"Hanson","year":"2012","journal-title":"PLoS One"},{"key":"2021031205091013500_CIT0049","doi-asserted-by":"crossref","first-page":"e01996","DOI":"10.1128\/JCM.01996-19","article-title":"Impact of the beta-glucan test on management of intensive care unit patients at risk of invasive candidiasis","volume":"58","author":"Kritikos","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2021031205091013500_CIT0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcrc.2016.06.026","article-title":"Comparison of 1,3-\u03b2-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients","volume":"36","author":"Lahmer","year":"2016","journal-title":"J Crit Care"},{"key":"2021031205091013500_CIT0051","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00134-012-2616-y","article-title":"Value of \u03b2-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions","volume":"38","author":"Le\u00f3n","year":"2012","journal-title":"Intensive Care Med"},{"key":"2021031205091013500_CIT0052","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","article-title":"Usefulness of the \u201cCandida score\u201d for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study","volume":"37","author":"Le\u00f3n","year":"2009","journal-title":"Crit Care Med"},{"key":"2021031205091013500_CIT0053","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10096-014-2239-z","article-title":"Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit","volume":"34","author":"Lo Cascio","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021031205091013500_CIT0054","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1093\/jac\/dkv090","article-title":"Candida biomarkers in patients with candidaemia and bacteraemia","volume":"70","author":"Mart\u00ednez-Jim\u00e9nez","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2021031205091013500_CIT0055","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/jac\/dkv241","article-title":"Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment","volume":"70","author":"Mart\u00ednez-Jim\u00e9nez","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2021031205091013500_CIT0056","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00134-015-3922-y","article-title":"\u03b2-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis","volume":"41","author":"Mart\u00edn-Mazuelos","year":"2015","journal-title":"Intensive Care Med"},{"key":"2021031205091013500_CIT0057","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/JCM.01240-10","article-title":"Prospective survey of (1\u21923)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting","volume":"49","author":"Mohr","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2021031205091013500_CIT0058","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1186\/cc13953","article-title":"Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation","volume":"18","author":"Poissy","year":"2014","journal-title":"Crit Care"},{"key":"2021031205091013500_CIT0059","doi-asserted-by":"crossref","first-page":"R249","DOI":"10.1186\/cc10507","article-title":"Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1\u21923)-\u03b2-D-glucan assay, Candida score, and colonization index","volume":"15","author":"Posteraro","year":"2011","journal-title":"Crit Care"},{"key":"2021031205091013500_CIT0060","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijid.2008.10.013","article-title":"Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients","volume":"13","author":"Presterl","year":"2009","journal-title":"Int J Infect Dis"},{"key":"2021031205091013500_CIT0061","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1164\/rccm.201211-2069OC","article-title":"\u03b2-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis","volume":"188","author":"Tissot","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2021031205091013500_CIT0062","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/myc.12267","article-title":"Reliability of serum 1,3-beta-D-glucan assay in patients undergoing renal replacement therapy: a review of the literature","volume":"58","author":"Prattes","year":"2015","journal-title":"Mycoses"},{"key":"2021031205091013500_CIT0063","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkw188","article-title":"Discontinuation of empirical antifungal therapy in ICU patients using 1,3-\u03b2-d-glucan","volume":"71","author":"Nucci","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2021031205091013500_CIT0064","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/jac\/dkw112","article-title":"(1,3)-\u03b2-d-glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study","volume":"71","author":"Posteraro","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2021031205091013500_CIT0065","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/myc.12221","article-title":"Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery","volume":"57","author":"Prattes","year":"2014","journal-title":"Mycoses"},{"key":"2021031205091013500_CIT0066","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/ciu074","article-title":"MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting","volume":"58","author":"Ostrosky-Zeichner","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021031205091013500_CIT0067","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/cid\/cis456","article-title":"(1,3)-\u03b2-D-glucan as a prognostic marker of treatment response in invasive candidiasis","volume":"55","author":"Jaijakul","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021031205091013500_CIT0068","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1128\/JCM.00773-12","article-title":"Correlation of clinical outcomes with \u03b2-glucan levels in patients with invasive candidiasis","volume":"50","author":"Sims","year":"2012","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/Supplement_2\/S102\/36550113\/ciaa1943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/Supplement_2\/S102\/36550113\/ciaa1943.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T05:10:09Z","timestamp":1615525809000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/72\/Supplement_2\/S102\/6168274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":68,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2021,3,12]]},"published-print":{"date-parts":[[2021,3,12]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1943","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,15]]},"published":{"date-parts":[[2021,3,12]]}}}